Elevated serum OCN levels significantly correlate with accelerated bone turnover in osteoporosis, serving as key biomarkers for diagnosing and monitoring postmenopausal osteoporosis (Mohammadi et al., 2024; Alam et al., 2019; Raymond et al., 1999). The gene discussed is BGLAP; the disease is osteoporosis.